PharmaBoardroom

Chinese Pharma’s Latest Race to the Bottom on Pricing

China's roll-out of a 25-province expansion to the 4+7 pilot procurement scheme has seen pharma companies scrambling to cut prices for their drugs…

Chinese Pharma Legal Update: October 2019

Fangda Partners' Josh Shin gives an overview of recent regulatory upgrades affecting the Chinese pharmaceutical industry. On August 26,…

Kevin Pan – CEO, Asieris, China

Kevin Pan, CEO of Asieris, shares the origins behind the company’s distinctive name and how it reflects their ambition to bridge scientific…

Irwin Wang – CEO, Reistone Biopharma, China

Dr Irwin Wang, CEO of Reistone Biopharma, shares her motivations behind the establishment of the company, their extremely productive collaboration…

Geoff Kau – Co-GM & CSO, Ping An Smart City, China

Geoff Kau, Co-GM and CSO of Ping An Smart City, introduces the breathtaking breadth of the Ping An healthcare ecosystem, and the interesting projects…

Charles Bark – Founder & CEO, HiNounou, China

Charles Bark, CEO and founder of HiNounou, shares the touching personal story of what inspired him to establish HiNounou as a complete remote…

5 Biotechs to Watch China October 2019

China-born entrepreneurs are returning to their homeland to find an industry filled with incentives in place for innovation, independent of generics.…

Jason Smith – SVP APACMEA; Gerry Muhle – VP,…

An exclusive interview with Jason Smith, SVP (Asia Pacific, Middle East and Africa); Gerry Muhle, VP (International Medical Aesthetics); and White…

Wang Wei – Founder & CEO, Winhealth Pharma, China

Wang Wei of Winhealth Pharma, one of China’s leading contract development and commercialisation organisations, outlines the rationale behind the…

Cheney Mao – Chairman & CEO, Viva Biotech, China

Dr Cheney Mao, chairman and CEO of Viva Biotech, shares the extremely unique business model of the company, which started as a highly specialized CRO…

A New Paradigm for Rare Diseases in China

Eric Bouteiller outlines the paradigm shift occurring in China around rare diseases and how the country has the potential to lead the global…

New China Pharma Report October 2019 Out Now

Download our latest pharma country report on China here 2019 is a landmark year for China, marking not only the 70th anniversary of the…

Tagged with China